Long-term Effects of Time to Treatment in Subarachnoid Haemorrhage

Spontaneous Subarachnoid Hemorrhage Clinical Trial

Official title:

Time From First Health Care Contact to Neurosurgical Admission and the Effect on Long-term Labour Market Affiliation and Mortality in Patients With Spontaneous Subarachnoid Haemorrhage

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04377347
• Other study ID #: Outcome
• Status: Completed
• Start date: May 1, 2020
• Est. completion date: February 24, 2021

Study information

• Verified date: February 2021
• Source: Rigshospitalet, Denmark
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

For patients with spontaneous subarachnoid haemorrhage, it remains to be investigated if there is an association between the time from patients call the Emergence Medical Coordination Center to neurosurgical admission and long-term outcome. This is a retrospective cohort study with four-year followup. The primary aim is to determine if the time to neurosurgical admission is associated to labour marked affiliation and mortality after four years.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 537
• Est. completion date: February 24, 2021
• Est. primary completion date: February 24, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Spontaneous subarachnoid haemorrhage registered in the Danish National Patient Register and confirmed by medical record review.
• Initially admitted to a hospital in the Capital Region of Denmark between 1 January 2008 and 31 December 2014.

Exclusion Criteria:

• Prior subarachnoid haemorrhage.
• Inhospital symptom onset.

Related Conditions & MeSH terms

• Hemorrhage
• Spontaneous Subarachnoid Hemorrhage
• Subarachnoid Hemorrhage

Intervention

Other:
• Time
Exposure is the time from patients call the Emergency Medical Coordination Center to they are admitted to a neurosurgiocal department.

Locations

Country	Name	City	State
Denmark	Rigshospitalet	Copenhagen

Sponsors (1)

Lead Sponsor	Collaborator
Rigshospitalet, Denmark

Country where clinical trial is conducted

Denmark, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Labour marked affiliation and mortality	The incidence of all-cause death and early retirement over the four-years after sSAH for different times to treatment is shown with Kaplan-Meier plots, and assessed with log-rank tests.	4 years